Cite
HARVARD Citation
Mato, A. et al. (2018). Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study. British journal of haematology. pp. 259-261. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mato, A. et al. (2018). Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study. British journal of haematology. pp. 259-261. [Online].